During the past decade, Volga District Med Center FMBA conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Volga District Med Center FMBA" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Volga District Med Center FMBA" are "Carcinoma, Transitional Cell" (1 trials), "Prostate Cancer" (1 trials), "Prostatic Neoplasms" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Volga District Med Center FMBA" in a lesser frequency.

Most popular intervention types in "Volga District Med Center FMBA" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Androgen deprivation therapy (ADT)" (1 trials), "Chemotherapy" (1 trials), "Darolutamide (Nubeqa, BAY1841788)" (1 trials), "Degarelix" (1 trials) and "Everolimus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Volga District Med Center FMBA" are 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Volga District Med Center FMBA". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Volga District Med Center FMBA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Volga District Med Center FMBA, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Volga District Med Center FMBA has several departments that took part in Clinical trials: "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" - 2 trials